Tag: big pharma

The Dark Side of Modern Medicine

A Century of Missteps, Manipulations, and Misdeeds. Medicine must be reclaimed as a public good, not a marketplace of manipulation.

The past century has seen astonishing medical advances, from antibiotics to organ transplants and precision diagnostics. Yet behind the celebrated breakthroughs lies a shadowed record of harm, deceit, and systemic failure.

The history of modern medicine is not only a story of progress but also one of unethical experimentation, corporate manipulation, regulatory capture, and public betrayal. I have witnessed this firsthand in my own career: when I proposed nutritional medicine approaches to prevention and early treatment, I was attacked by medical boards, chastised by medical colleges and silenced by bureaucracies beholden to pharmaceutical interests.

My work on vitamin C, cancer, and AIDS brought harassment from authorities, culminating in legal battles I was forced to fight—and win in the Supreme Court —at great personal cost. During the COVID-19 pandemic, my pleas to government leaders to adopt simple, life-saving measures like vitamin D, C and zinc were ignored, while experimental genetic injections were pushed on the public without transparency or informed consent.

Over decades I have seen colleagues censured, evidence suppressed, and patients left to suffer—all because profit and political control took precedence over genuine health and healing. Its still happening and patients are dying unnecessarily from the turbo cancers caused by the mRNA vaccines.

The pattern begins with unethical human experimentation and consent failures. In certain landmark cases over the past decades we find medical science mis-stepping into exploitation — from the decades-long denial of treatment in the Tuskegee Syphilis Study, to more recent oversight-failures in clinical trials in low-income countries when pharmaceutical firms prioritised expedience over ethics.

I have observed similar dynamics in my own work: when simple nutritional protocols were sidelined, when investigative treatment options were blocked on the grounds of “non-standard care”, even though patient welfare was at stake, and when regulatory and board actions were taken not for patient safety but to suppress dissenting therapeutic voices.

Next comes the distortion of data, selective reporting and publication bias. The re-analysis of Study 329 revealed that the antidepressant paroxetine was neither safe nor effective in adolescents, despite original favourable publications.

Keep reading

Smoke, Mirrors, and the Pfizer Deal

Iam a mother. I have never been vaccinated myself. I believe deeply in informed consent. And I want to say clearly that I am hopeful about Bobby’s leadership at HHS. I want to believe that he can bring real transparency and accountability to a government that has too often cozied up to the corporations it is supposed to regulate.

But when I read the headlines about Trump’s “landmark” deal with Pfizer, I don’t feel hopeful. I feel misled.

We are told that Pfizer has committed $70 billion to research, development, and production here in the United States. That sounds impressive, like a historic victory for the American people. But the truth is, Pfizer already spends billions every year on research and development. That is simply the business they are in. Without that constant pipeline, they do not survive.

So what is really new here? Nothing at all. It is the same budget they were already going to spend, repackaged and sold as a bold new commitment. The difference now is that Pfizer gets something in return: tariff relief, political cover, and a government-backed direct-to-consumer program called TrumpRx.

That is what makes this deal so frustrating. Pfizer is not changing its behavior. They are not suddenly sacrificing profits or doing more for patients. They are being rewarded for business as usual, only now with added advantages that strengthen their market position even more. And we are being asked to celebrate it as if it is some great victory for ordinary families.

Every producer wants to cut out the middleman. I know this from my own life. As a meat producer, I do not want to pay one. As a vegetable producer, I do not want to pay one. As a content creator, I do not want to pay one. Nobody does. And now Pfizer, of all companies, is getting the official blessing of the US government to do exactly that.

This is the same Pfizer that misled the public during Covid. That is not a rumor, it is documented. Whistleblowers from trial sites described falsified records, patients who were not properly followed up after adverse events, and unqualified staff handling sensitive data. State attorneys general have accused Pfizer of downplaying serious risks, including heart inflammation in young men and pregnancy complications in women. 

Kansas has even claimed the company hid internal studies that showed risks while telling the public something different. And the most central promise of all, that the vaccines would stop transmission, simply was not true, even though the marketing never caught up to that reality.

Keep reading

Is Your Medication Made in a Contaminated Factory? The FDA Won’t Tell You.

They were the sort of disturbing discoveries that anyone taking generic medication would want to know.

At one Indian factory manufacturing drugs for the United States, pigeons infested a storage room and defecated on boxes of sterilized equipment. At another, pathogens contaminated purified water used to produce drugs. At a third, stagnant urine pooled on a bathroom floor not far from where injectable medication was made.

But when the Food and Drug Administration released the grim inspection reports and hundreds of others like them, the agency made a decision that undermined its mission to protect Americans from dangerous drugs.

Instead of sharing the names of the medications coming from the errant foreign factories, the FDA routinely blacked them out, keeping the information secret from the public. That decision prevented doctors, pharmacists and patients from knowing whether the drugs they counted on were tainted by manufacturing failures — and potentially ineffective or unsafe.

“Is there some quality issue? Is there a greater difference in potency than expected? Is there a contaminant? I don’t know,” said Dr. Donna Kirchoff, a pediatrician in Oregon who has spent hours trying to find out where certain drugs were made for patients reporting unexplained reactions.

There’s no specific requirement that the FDA block out drug names on inspection reports about foreign facilities. Still, the agency preemptively kept that information hidden, invoking a cautious interpretation of a law that requires the government to protect trade secrets.

It’s part of a decades-long pattern of discounting the interests of consumers who want to make informed choices about the drugs they take — even as 9 out of 10 prescriptions in the United States are filled with generics, many from India and China.

Keep reading

City Health Officials Tied to Soros Urge Public to “Get Vaccinated”

A coalition of city public health officials with ties to pharma investor George Soros is urging the public to “get vaccinated.”

In an open letter, the Big Cities Health Coalition accused federal officials of driving down vaccination rates and fueling an increase in dangerous infectious disease outbreaks by making “repeated false claims” about vaccines.

They wrote:

“Vaccines have eradicated devastating diseases and saved millions of lives. They keep classrooms safe and schools open. They allow children to spend time with friends and enjoy their favorite activities. They help parents and caregivers work to support their families.

The letter also addresses recent changes to the Centers for Disease Control and Prevention’s (CDC) recommended vaccine schedule for children and adults, though it does not mention U.S. Health Secretary Robert F. Kennedy Jr. or President Donald Trump by name.

The coalition, which represents 35 U.S. cities and about a fifth of the U.S. population, “has been working together to exchange ideas and address public health threats for more than two decades,” according to CNN, which first reported on the letter Monday.

Participating cities include New York, Los Angeles, Chicago, Boston, Houston, Dallas, Cleveland, Milwaukee and Seattle.

The group’s financial documents reveal support from billionaire financier Soros. Soros has also invested heavily in the pharmaceutical industry, including COVID-19 vaccine makers Pfizer and AstraZeneca, and Gilead Sciences, which produces remdesivir, a controversial antiviral treatment frequently given to COVID-19 patients.

Keep reading

How Vaccine Brain Injuries Were Rebranded and Erased From Memory

I’ve long believed that public relations (propaganda) is one of the most powerful but invisible forces in our society. Again and again, I’ve watched professional PR firms create narratives that most of the country believes, regardless of how much it goes against their self-interests. What’s most remarkable is that despite the exact same tactics being used repeatedly on the public, most people simply can’t see it. When you try to point out exactly how they’re being bamboozled by yet another PR campaign, they often can’t recognize it—instead insisting you’re paranoid or delusional.

That’s why one of my major goals in this publication has been to expose this industry. Once you understand their playbook—having “independent” experts push sculpted language that media outlets then repeat—it becomes very easy to spot, and saves you from falling into the traps most people do. The COVID-19 vaccines, for instance, were facilitated by the largest PR campaign of our lifetime.

One of the least appreciated consequences of this industry is that many of our cultural beliefs ultimately originate from PR campaigns. This explains why so many widely believed things are “wrong”—if a belief were actually true, it wouldn’t require a massive PR investment to instill in society. Due to PR’s power, the viewpoints it instills tend to crowd out other cultural beliefs.

In this article, we’ll take a deeper look at what’s behind one of those implanted beliefs: “vaccines don’t cause autism.”

Keep reading

FDA Stayed Silent As Internal Reports About Potential Tylenol Risks Piled Up

The Food and Drug Administration (FDA) defied the advice of its own drug safety experts to warn pregnant women about Tylenol for nearly a decade, internal reports and presentations obtained by the Daily Caller News Foundation reveal.

FDA rank-and-file scientists repeatedly recommended the agency release information about Tylenol in pregnancy across three scientific reviews conducted in 2016, 2019, 2022 and two memos, one from the FDA’s maternal health division in 2016 and one from the FDA’s urological health division in 2017.

The scientific literature posits many plausible drivers of autism, the most well-established of which are genetic, and the FDA drug safety experts acknowledged that the research linking the condition to Tylenol is far from ironclad.

Still, as alarm bells rang within FDA headquarters and the boardrooms of Tylenol’s manufacturers, pregnant women heard nothing from either the government or the manufacturers about the potential risks until the September announcement by President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr.

FDA leadership declined to update its webpage about over-the-counter painkillers in pregnancy, repeatedly falling back on language first issued in January 2015. But that statement simply acknowledged that “FDA is aware of concerns” about Tylenol and attention deficit hyperactivity disorder (ADHD), citing just one scientific paper.

At the urging of Trump and Kennedy, FDA finally released a nuanced statement in September cautioning pregnant women about Tylenol while acknowledging that aspirin, ibuprofen and high fevers all pose their own risks. That move was first recommended by an FDA drug safety expert nine years earlier.

The DCNF obtained the FDA documents from the law firm Keller Postman LLC, which brought a class action lawsuit against Tylenol maker Kenvue, a legally independent spinoff of Johnson & Johnson. The personal injury law firm, which often brings class action lawsuits, obtained the documents from FDA via the Freedom of Information Act.

Tylenol, a brand name for acetaminophen, first received FDA approval in 1955 before modern drug laws tightened clinical trial requirements in 1962.

Some experts argue that neurological damage occurs due to a toxic byproduct of acetaminophen called NAPQI. Babies and children with autism may struggle to metabolize the drug, resulting in higher levels of NAPQI, which kills cells.

Keep reading

The DARK UNDERBELLY of Weight Loss ‘Miracle’ Drugs

Now, first, let me get one thing outta the way. No, I’ve never really struggled with weight issues. I do have my issues (definitely some screws loose), but poor physical health has never been one of them.

Of course, I’m relatively young.

So what I’m saying is, I certainly cannot relate to people who are constantly overweight despite their best efforts, let alone somebody who is bordering on morbidly obese.

I’ve always had a fast metabolism, and for the most part, I’ve always been active, competitive in sports throughout high school and college. But I’ve also been lucky. Still, I continuously prioritize whole, clean eating when I can, getting out in nature, and regularly doing other things that maybe those darn tree-huggers were right about all along…

Okay. Now that that’s outta the way…

Have you noticed that many people who have hopped on the ‘fat shot’ were also highly supportive of the COVID injections at some point?

Although many of them – even those who were giddy to get jabbed – have fallen quiet about the “mmRNA” in recent times, perhaps realizing they were duped, that hasn’t stopped them from buying into the next big thing, in this case: Big Pharma’s panacea.

It’s good for diabetes! It’s good for weight loss! It’s good for your heart! It’s going to make you live foreeeeeever!!

Keep reading

Popular hair-loss pill linked to depression and suicide

A new analysis by a public health expert at the Hebrew University of Jerusalem has found that finasteride, a widely used treatment for hair loss, has been associated with depression and suicide for more than twenty years. Despite these long-standing concerns, neither regulators nor the drug’s manufacturer took meaningful action. Drawing on adverse event reports and health records from several countries, the review identifies a consistent pattern of psychiatric side effects linked to the drug. Even with growing evidence, both Merck and the FDA failed to launch necessary safety investigations. The author is now urging major reforms to the way medications are approved and monitored for long-term risks.

For more than two decades, finasteride has been prescribed to millions of men seeking to slow or reverse hair loss. Behind its cosmetic appeal, however, evidence has continued to emerge suggesting serious mental health consequences, including depression, anxiety, and in some cases, suicide.

Prof. Mayer Brezis of the Hebrew University of Jerusalem argues that both the medical community and regulators have repeatedly failed to protect the public by overlooking signs of psychiatric harm associated with the drug.

His review analyzed data from eight large studies published between 2017 and 2023. The findings show a clear trend: people who used finasteride were far more likely to experience mood disorders and suicidal thoughts than those who did not. This pattern appeared consistently across various national databases, including the FDA’s adverse event system and healthcare records from Sweden, Canada, and Israel.

“The evidence is no longer anecdotal,” said Prof. Brezis, a professor emeritus of medicine and public health. “We now see consistent patterns across diverse populations. And the consequences may have been tragic.”

The report estimates that hundreds of thousands of users may have suffered from finasteride-related depression, and that hundreds — possibly more — may have died by suicide. Originally approved by the FDA in 1997 for male pattern baldness, the drug has remained popular for its perceived safety and effectiveness, particularly among younger men. Critics say, however, that its risks were downplayed or ignored.

Keep reading

President Trump Announces Major Deal with Drugmaker AstraZeneca, Including $50 BILLION Investment

President Trump on Friday announced another deal with UK-based pharmaceutical company AstraZeneca to lower drug costs for Americans on Medicaid. 

The drug manufacturer will now sell prescription drugs to patients at Most Favored Nations prices through TrumpRx.gov.

This comes after the President struck a deal with Pfizer to also provide Americans with heavily discounted prescription drugs at most-favored-nation prices.

Trump made the announcement on AstraZeneca in the Oval Office on Friday, where he touted his efforts to lower drug costs during his first term and announced Most Favored Nations pricing from “the largest pharmaceutical manufacturer in the United Kingdom.”

“I had it going very well in my first term, but we were interrupted by rigged elections, so I was unable to carry it forward,” the President noted.

Trump also highlighted AstraZeneca’s plans to build a new plant in Charlottesville, Virginia, where they broke ground on Thursday, investing $50 billion in U.S. manufactuting, he said. “It’s going to have 3,600 jobs just to begin with, and that’s going to be a fantastic plant,” Trump said.

Trump delivered remarks on the new deal and AstraZeneca’s manufacturing plans in America for nearly seven minutes before taking questions from the press. AstraZeneca CEO Pascal Soriot, Health and Human Services Secretary Robert F. Kennedy Jr, CMS Administrator, Mehmet Oz, FDA commissioner Marty McCary, and Virginia Governor Glenn Youngkin joined the President and delivered remarks.

Keep reading

Self-Monitoring Blood Glucose Meters Recalled Due to Potentially Defective Displays: FDA

Florida-based Trividia Health Inc. is recalling a limited number of blood glucose meters because of potentially defective liquid-crystal displays that could affect product performance, the company said in an Oct. 7 statement published by the Food and Drug Administration.

The recall applies to Trividia’s True Metrix self-monitoring glucose meters that are co-branded under the Good Neighbor Pharmacy brand. The affected items belong to lot number KD0746, printed on the side of the product box. They were manufactured on Sept. 4 and sold between Sept. 8 and 16 across the United States.

“It is possible that the LCD display for the affected products may show partial or missing numerical segments or characters or show ghosting (fading) of numerical segments or characters,” the company said. “As a result, it is possible that users could misinterpret a test result or experience a delay in obtaining test results. For users with low glucose (hypoglycemia), this could result in a delay in treatment or therapy decisions.”

According to Trividia, it has so far not received any reports of people suffering injuries as a result of using the recalled products.

The company said it was sending notifications to customers, including pharmacies, to inform them of the issue.

“If you have an affected Product, the Trividia Health Customer Care Department will help with return and replacement information,” it said.

Keep reading